Scopus – indexing of journals
1. Smirnova M.D., Ryazanov A.S., Yurenev A.P. DYNAMIC MONITORING OF PATIENTS WITH HCMP IN THE SCIENTIFIC ADVISORY DEPARTMENT. Cardiology. 2000. № 9. P. 45.
2. Ryazanov A.S., Gabbasov Z.A., Yurenev A.P. PLATELET AGGREGATION IN PATIENTS WITH VARIOUS FORMS OF LEFT VENTRICULAR HYPERTROPHY AND ITS CHANGES DURING LONG-TERM OBSERVATION AND TREATMENT. Therapeutic Archive. 2000. Vol. 72. № 11. P. 50-54.
3. Ryazanov A.S., Gabbasov Z.A., Yurenev A.P. THE STATE OF PLATELET AGGREGATION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY. Therapeutic Archive. 2000. № 8. P. 36-38.
4. Ryazanov A.S., Smirnova M.D., Yurenev A.P. LEFT VENTRICULAR MYOCARDIAL HYPERTROPHY. Therapeutic Archive. 2000. № 2. P. 88.
5. Ryazanov A.S., Smirnov M.D., Yurenev A.P. LEFT VENTRICULAR MYOCARDIAL HYPERTROPHY. PATHOGENESIS ISSUES. Therapeutic Archive. 2000. № 2. P. 72.
6. Ryazanov A.S. CLINICAL AND GENETIC ASPECTS OF LEFT VENTRICULAR MYOCARDIAL HYPERTROPHY DEVELOPMENT. Russian Cardiology Journal. 2003. № 2. P. 93.
7. Ryazanov A.S., Arakelyantz A.A., Yurenev A.P. HYPERTENSIVE HEART. STATE OF THE PROBLEM. Clinical Medicine. 2003. Vol. 81. № 6. P. 15-18.
8. Ryazanov A.S., Arakelyantz A.A., Yurenev A.P. PATHOGENESIS OF ARTERIAL HYPERTENSION WITHIN METABOLIC SYNDROME. Therapeutic Archive. 2003. Vol. 75. № 3. P. 86-88.
9. Arakelyantz A.A., Zhukova N.V., Ryazanov A.S., Yurenev A.P. MICROALBUMINURIA: CLINICAL AND PROGNOSTIC SIGNIFICANCE IN ARTERIAL HYPERTENSION. Therapeutic Archive. 2003. Vol. 75. № 12. P. 81-82.
10. Arakelyantz A.A., Zhukova N.V., Ryazanov A.S. MICROALBUMINURIA: CLINICAL AND PROGNOSTIC SIGNIFICANCE IN ARTERIAL HYPERTENSION. Therapeutic Archive. 2008. Vol. 75. P. 47.
11. Ryazanov A.S., Eremenko N.N., Kireev S.A., Kudryavtsev A.A. ACHIEVING TARGET BLOOD PRESSURE LEVELS IN PATIENTS WITH ARTERIAL HYPERTENSION OF STAGES 2-3 USING FIXED COMBINATIONS OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE. Rational Pharmacotherapy in Cardiology. 2010. Vol. 6. № 6. P. 832-836.
12. Kudryavtsev A.A., Ryazanov A.S., Eremenko N.N., Kireev S.A. DYNAMICS OF LEFT VENTRICULAR MYOCARDIAL MASS INDEX IN PATIENTS WITH ARTERIAL HYPERTENSION OF STAGES II-III DURING THERAPY WITH CO-RENITEC AND GIZAAR. Obesity and Metabolism. 2010. Vol. 7. № 4. P. 36-38.
13. Ryazanov A.S., Kireev S.A., Eremenko N.N. SPIROGRAPHIC CHARACTERISTICS OF COPD PATIENTS WITH METABOLIC SYNDROME DEPENDING ON BODY WEIGHT. Obesity and Metabolism. 2010. Vol. 7. № 3. P. 28-30.
14. Ryazanov A.S., Kireev S.A., Eremenko N.N. CLINICAL COURSE FEATURES OF COPD WITH METABOLIC SYNDROME: THE ROLE OF SYSTEMIC INFLAMMATION. Obesity and Metabolism. 2010. Vol. 7. № 2. P. 49-51.
15. Kudryavtsev A.A., Ryazanov A.S., Eremenko N.N. EVALUATION OF DAILY BLOOD PRESSURE MONITORING INDICATORS WHEN USING FIXED COMBINATIONS OF CO-RENITEC AND GIZAAR AND THEIR COMBINATIONS WITH ACUPUNCTURE IN PATIENTS WITH ARTERIAL HYPERTENSION. Questions of Balneology, Physiotherapy, and Therapeutic Physical Culture. 2011. № 2. P. 5-7.
16. Ryazanov A.S., Kapitonov K.I., Makarovskaya M.V., Kudryavtsev A.A. INFLUENCE OF CONTINUOUS NITRATE INTAKE ON DISEASE PROGNOSIS IN PATIENTS WITH VASOSPASTIC ANGINA ACCORDING TO LONG-TERM OUTPATIENT OBSERVATION. Cardiovascular Therapy and Prevention. 2018. Vol. 18. № 4. P. 19-24.
17. Ryazanov A.S., Makarovskaya M.V., Kapitonov K.I., Kudryavtsev A.A. PROGNOSTIC SIGNIFICANCE OF LEFT VENTRICULAR MASS INDEX IN PATIENTS WITH MILD AND MODERATE AORTIC STENOSIS. Cardiovascular Therapy and Prevention. 2018. Vol. 18. № 2. P. 32-37.
18. Ryazanov A.S., Makarovskaya M.V., Kapitonov K.I., Kudryavtsev A.A. FEATURES OF AORTIC VALVE CALCIFICATION IN AORTIC STENOSIS IN MEN AND WOMEN. Clinical Medicine. 2019. Vol. 97. № 4. P. 260-266.
19. Ryazanov A.S., Kapitonov K.I., Makarovskaya M.V., Kudryavtsev A.A. EFFECTIVENESS OF ANGIOTENSIN RECEPTOR AND NEPRILYSIN INHIBITORS IN FUNCTIONAL MITRAL REGURGITATION. Clinical Medicine. 2020. Vol. 98. № 2. P. 106-114.
20. Ryazanov A.S., Kapitonov K.I., Makarovskaya M.V., Kudryavtsev A.A. RESULTS OF USING ANGIOTENSIN RECEPTOR AND NEPRILYSIN INHIBITORS IN SECONDARY FUNCTIONAL MITRAL REGURGITATION IN OUTPATIENT PRACTICE. Annals of the Russian Academy of Medical Sciences. 2020. Vol. 75. № 5. P. 514-522.
21. Ryazanov A.S., Shikh E.V., Kapitonov K.I., Makarovskaya M.V., Kudryavtsev A.A. INFLUENCE OF ANGIOTENSIN RECEPTOR AND NEPRILYSIN INHIBITORS ON AORTIC RIGIDITY IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION. Annals of the Russian Academy of Medical Sciences. 2021. Vol. 76. № 3. P. 298-306.
22. Ryazanov A.S., Shikh E.V., Kechina O.V., Makarovskaya M.V., Kudryavtsev A.A. INFLUENCE OF ANGIOTENSIN RECEPTOR AND NEPRILYSIN INHIBITORS ON QUALITY OF LIFE IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION AND FUNCTIONAL MITRAL REGURGITATION. Rational Pharmacotherapy in Cardiology. 2022. Vol. 18. № 6. P. 662-668.
23. Ryazanov A.S., Shikh E.V., Makarovskaya M.V., Kudryavtsev A.A. ANGIOTENSIN RECEPTOR AND NEPRILYSIN INHIBITORS AND HEART REMODELING. Brazilian Journal of Medical and Biological Research. 2023. Vol. 56. P. e12616.
24. Markova E.Yu., Kechin E.V., Avakyantz G.V., Tarasova N.S., Ryazanov A.S. PREDICTING CLINICAL AND MORPHOFUNCTIONAL RESULTS OF CORNEAL COLLAGEN CROSSLINKING IN CHILDREN. Ophthalmosurgery. 2023. № 4. P. 50-55.
25. Ryazanov A.S., Melnikova L.V., Makarovskaya M.V., Kechina O.V. EFFICACY OF SACUBITRIL/VALSARTAN COMPARED TO VALSARTAN IN PATIENTS WITH ARTERIAL HYPERTENSION. Arterial Hypertension. 2024. Vol. 30. № 2. P. 175-180.